Citius Pharmaceuticals (NASDAQ:CTXR) Issues Earnings Results
Citius Pharmaceuticals (NASDAQ:CTXR – Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.06) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.01), Zacks reports. Citius Pharmaceuticals Price Performance Shares of NASDAQ CTXR traded down $0.08 during midday trading on Tuesday, reaching $0.61. 4,031,109 shares of […]
More Stories
Autodesk, Inc. (NASDAQ:ADSK) Shares Sold by Trustmark National Bank Trust Department
Trustmark National Bank Trust Department reduced its stake in shares of Autodesk, Inc. (NASDAQ:ADSK – Free Report) by 22.5% in...
First Horizon Advisors Inc. Purchases 350 Shares of The Boeing Company (NYSE:BA)
First Horizon Advisors Inc. raised its holdings in The Boeing Company (NYSE:BA – Free Report) by 7.1% in the 3rd...
Landscape Capital Management L.L.C. Acquires 520 Shares of Parker-Hannifin Co. (NYSE:PH)
Landscape Capital Management L.L.C. lifted its holdings in shares of Parker-Hannifin Co. (NYSE:PH – Free Report) by 25.7% during the...
Navellier & Associates Inc. Sells 850 Shares of Applied Industrial Technologies, Inc. (NYSE:AIT)
Navellier & Associates Inc. lessened its stake in shares of Applied Industrial Technologies, Inc. (NYSE:AIT – Free Report) by 23.7%...
Hyatt Hotels Co. (NYSE:H) Shares Sold by Massachusetts Financial Services Co. MA
Massachusetts Financial Services Co. MA trimmed its holdings in shares of Hyatt Hotels Co. (NYSE:H – Free Report) by 6.5%...
Church & Dwight Co., Inc. (NYSE:CHD) Stake Trimmed by Commerce Bank
Commerce Bank cut its position in shares of Church & Dwight Co., Inc. (NYSE:CHD – Free Report) by 1.2% in...